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Abstract
Background: Hemichorea–hemiballismus involves unilateral involuntary flailing movements and random jerking movements involving proximal or distal
muscles. We describe a case of hemichorea–hemiballismus with dystonia after stroke. Treatment with tetrabenazine and chemodenervation produced beneficial
responses. Effective treatment of both hemichorea–hemiballismus and dystonia due to stroke has not been reported.
Case Report: A 65-year-old male developed left hemichorea–hemiballismus and dystonia after a right hemisphere stroke. He underwent initial treatment with
neuroleptics and anticonvulsants without improvement. Subsequent treatment with tetrabenazine improved the hemichorea–hemiballismus and chemodenervation
reduced the dystonia.
Discussion: Hemichorea–hemiballismus associated with dystonia can be improved with both tetrabenazine and chemodenervation.
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Introduction
Hemichorea–hemiballismus (HCHB) is characterized by involun-
tary unilateral irregular flailing movements and continuous random
jerking movements of proximal or distal muscles.1,2 Cortical strokes
have less commonly been described as an etiology of HCHB
as most reported cases are due to subcortical strokes or from a
metabolic cause such as hyperglycemia. In one study of 5,009 post-
stroke patients, 27 patients developed hemichorea whereas only six
of those patients had a cortical lesion.3 Some individuals with HCHB
also develop dystonia, and in such cases an effective treatment strategy
is not yet established. We herein present a case of HCHB associated
with dystonia after a right hemispheric stroke. The patient was treated
with tetrabenazine and chemodenervation, with overall beneficial
responses to both. The combination of these two treatment modalities
for the management of HCHB with dystonia has not been formally
described.
Case report
A 65-year-old male with a history of diabetes mellitus, chronic
obstructive pulmonary disease, depression, and a right hemisphere
stroke presented to the Johns Hopkins Movement Disorders Clinic for
evaluation of left-sided involuntary hyperkinetic movements. The
hyperkinetic movements began 3 months after a stroke involving the
right posterior frontal lobe white matter and small cortical infarcts in
the right temporal–frontal–parietal junction (Figure 1). On evaluation,
he was noted to have distal choreic movements and proximal
ballistic swings of moderate amplitude involving the left arm (Video
Segment 1). The hyperkinetic movements were more pronounced with
action and interfered with volitional left-sided movements. There was
mild weakness of the left triceps and left tibialis anterior with mild
increased left arm muscle tone. His sensory examination was normal.
Based on his history and examination, he was diagnosed with post-
stroke HCHB syndrome.
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Serial videotaped evaluations were performed. Smaller amplitude
choreic movements of the left leg were intermittent and were best
captured during the post-treatment interval (Video Segment 2). He
also had dystonic posturing of his left arm behind his back, flexor
posturing of his left finger digits, and dystonic left foot inversion (Video
Segment 2).
Initial treatments included total daily doses of haloperidol (3.5 mg),
risperidone (1 mg), baclofen (30 mg), and valproic acid (1,500 mg) at
separate, successive intervals, each with intolerable side effects of
sedation and/or limited efficacy. This was followed by treatment with
tetrabenazine 12.5 mg three times a day with partial reduction of the
hyperkinetic movements (Video Segment 3). Ten months after he
initiated tetrabenazine 12.5 mg three times a day, he reported fatigue.
An attempt to gradually taper off the medication resulted in worsening
HCHB. As a result of persistent left HCHB after several days of
discontinuation, tetrabenazine was restarted and gradually increased
Figure 1. Magnetic Resonance Imaging of the Brain Showing Strokes
in the Right Cerebral Hemisphere. Diffusion-weighted (A, C,) and
corresponding apparent diffusion coefficient (B, D) images showing multiple small
acute lacunar-type infarcts.
Video Segment 1. Before Treatment with Chemodenervation or
Tetrabenazine.
The patient has hemichorea–hemiballismus of the left arm.
Video Segment 2. After Treatment with Chemodenervation and
Tetrabenazine 12.5 mg bid.
The patient has hemichorea–hemiballismus of the left arm, chorea of the left leg,
left arm dystonia, and dystonic left foot inversion. Hyperkinetic movements and
dystonia are reduced after treatment.
Video Segment 3. After Treatment with Chemodenervation and
Tetrabenazine 12.5 mg tid.
Hyperkinetic movements and dystonia are reduced after treatment.
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over a period of 2 weeks to 12.5 mg bid, which the patient tolerated
with reduced hyperkinetic movements.
The persistent dystonic posturing of the left arm behind his back
led to severe shoulder pain and functional impairment. He was
subsequently started on treatment with onabotulinumtoxinA approxi-
mately 9 months after the onset of the HCHB movements. He received
a total of 155 units of onabotulinumtoxinA by injection to the left
infraspinatus (30 units), left pectoralis major (30 units), left deltoid
(30 units), left flexor carpi radialis (20 units), left flexor carpi ulnaris
(25 units), and left extensor carpi radialis (20 units). After several
treatments with onabotulinumtoxinA injections, he reported a
moderate reduction of the dystonia with functional improvement
of the left arm (Video Segment 3). He was continued on
onabotulinumtoxinA injections every 3–6 months along with tetra-
benazine 12.5 mg twice a day with improvement of the hyperkinetic
movements and dystonia.
Discussion
We report a case of HCHB with associated dystonia. The term
hemichorea–hemiballismus represents a spectrum of hyperkinetic
movement disorders varying in the severity of choreic and/or ballistic
movements.1,2 HCHB cases have been previously described with
associated dystonia; however, the exact mechanism for the variability
in phenomenology is not well understood. Dewey and Jankovic1
reported that 10 out of 21 patients with HCHB were likely associated
with stroke. Six out of those 10 patients were also characterized as
having dystonia with varied lesion locations, including subcortical and
cortical regions.1 Additionally, post-stroke dystonia–chorea of a jerky
quality has been described, typically associated with thalamic stroke
and sensory loss.4,5 The variability in the phenomenology of stroke-
induced HCHB is likely to be a result of the lesion location and the
degree of disruption of cortical and/or subcortical structures that
regulate movement.
Cortical strokes are less commonly associated with HCHB. A
unique aspect of the case was the development of HCHB after a stroke
involving the cortex and subcortical white matter. Diffusion-weighted
magnetic resonance imaging (MRI) of the brain (Figure 1) showed
multiple areas of lacunar-type infarcts involving the right posterior
frontal lobe white matter and small cortical infarcts in the right
temporal–frontal–parietal junction. Isolated subthalamic lesions have
been associated with pure hemiballismus;6 however, one specific
location has not been identified as the cause of HCHB. In a clinical–
radiological study of post-stroke hemichorea patients, lesion location
included the caudate, putamen, subthalamus, globus pallidus, and
cerebral cortex.3 Similar to six patients in this study, our case had a
cortical stroke in the middle cerebral artery territory. Proposed
theories for the association of cortical lesions with HCHB include
interruption of the cortical–basal ganglia pathways or the presence of a
concurrent small basal ganglia infarct not detected on MRI.3
While some patients with post-stroke HCHB spontaneously resolve,
others may have persistent symptoms that are difficult to treat.
Interestingly, our case had both HCHB and dystonia. To our
knowledge, treatment of post-stroke HCHB with associated dystonia
has not been previously described. In one prior case of hyperglycemia-
induced hemichorea and bilateral dystonia, the involuntary move-
ments resolved after treatment with insulin and haloperidol.7 While
neuroleptics and anticonvulsants have been shown in some case series
to improve HCHB symptoms,1 these treatments failed to control the
hyperkinetic movements in our case.
Tetrabenazine has been used in the treatment of hyperkinetic
movement disorders, including Huntington disease, tardive dyskinesia,
and hemiballismus from lesions of the subthalamic nucleus.8 Despite
its varied indications, the use of tetrabenazine in individuals
with HCHB has not been widely reported. One previous study on
hyperglycemia-induced HCHB showed excellent control of the HCHB
with tetrabenazine.2 Our patient demonstrated good control of his
left HCHB on tetrabenazine and had noticeable worsening of his
hyperkinetic movements in one instance when tetrabenazine was
temporarily discontinued. The mechanism by which tetrabenazine
alters the underlying pathophysiology of HCHB is not fully under-
stood, but is likely related to its effect in depleting central dopamine
levels with consequent interruption of the cortical–basal ganglia
networks. Tetrabenazine is an inhibitor of the vesicular monoamine
transporter 2, and thus prevents the release of monoamines and also
acts as a mild dopamine receptor blocker.2
While our case showed reduced HCHB on tetrabenazine, he
continued to have episodic dystonic posturing of his left arm.
Chemodenervation is a safe and effective treatment for focal dystonias
including limb dystonia.9 Improvement of focal dystonias after
treatment with chemodenervation can last up to 3 months and in
many cases results in an improved functional ability of the limb. Our
case reported a reduction of his left arm dystonia after chemodenerva-
tion treatments. In refractory cases of HCHB associated with dystonia,
dual therapy with tetrabenazine and chemodenervation should be
considered as a treatment strategy to maximize benefit and minimize
functional disability.
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